Cabenuva seemed to be a cure for adherence issues while treating HIV, so why is accessing it so hard?

Dr. Carly Floyd joins the podcast to discuss issues with Cabenuva billing that has negatively impacted many patients, providers and clinics around the US.  What seems like it should be simple approval process has turned into a medical billing nightmare that limits patients access, costs some clinics to lose money and has been a major issue with how we treat HIV.  Increased opacity is never good in healthcare billing.

Join AAHIVM here:
https://aahivm.org/

Read more on Cabenuva issues here: 
https://aahivm.org/wp-content/uploads/2021/03/Long-Acting-ARVs-_Final-2-25-21_PDF.pdf

https://www.floridahealth.gov/diseases-and-conditions/aids/adap/_documents/FINAL5BarrierstoLA-ARVsResourceSheetforProviders.pdf

http://aidsnet.org/wp-content/uploads/2021/11/3-cabenuva-nov-19-2021-version.pdf

Reach out to Dr. Floyd here: https://www.linkedin.com/in/carlycloudfloyd/

Episode 128 - Issues with Cabenuva Billingand Access withDr.Carly Floyd

The podcast that focuses on the political side of pharmacy.
We will tackle the big and hot topics in the pharmacy world and discuss how they have become what they are and provide calls to action.  Our guests include pharmacists with professional areas of practice that cover the topic up for discussion or people with extensive knowledge of the topic.  Occasionally, there might even be a politician who joins us.

Episode 128 - Issues with Cabenuva Billingand Access withDr.Carly Floyd

Political Pharmacist